DXCM
DexCom, Inc.
Medical Devices · Healthcare · United States
91.48
close · 2026-08-13
value
15
cheaper than peers15
quality
95
stronger fundamentals95
ranked against
Medical Devices
value
quality
55 peerswide variation
Value inputs
| measure | company | vs peers |
| forward P/E | 29.28× | 36 |
| EV to EBITDA | 21.84× | 32 |
| price to sales | 6.30× | 19 |
| price to book | 13.17× | 12 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 38.5% | 99 |
| operating margin | 24.3% | 94 |
| debt to equity | 53.3% | 58 |
| revenue growth | 13.1% | 57 |
4 of 4 measures available
Facts
| market cap | $35B |
| free cash flow | $1.02B |
| employees | 11,000 |
| first trade | 2005-04-14 |
| next earnings | 2026-07-30 |
| fundamentals updated | 2026-08-06 |